SG11202002570WA - Methods for determining selectivity of test compounds - Google Patents

Methods for determining selectivity of test compounds

Info

Publication number
SG11202002570WA
SG11202002570WA SG11202002570WA SG11202002570WA SG11202002570WA SG 11202002570W A SG11202002570W A SG 11202002570WA SG 11202002570W A SG11202002570W A SG 11202002570WA SG 11202002570W A SG11202002570W A SG 11202002570WA SG 11202002570W A SG11202002570W A SG 11202002570WA
Authority
SG
Singapore
Prior art keywords
methods
test compounds
determining selectivity
selectivity
determining
Prior art date
Application number
SG11202002570WA
Other languages
English (en)
Inventor
Nikolaus Krall
Giulio Superti-Furga
Gregory Vladimer
Original Assignee
Cemm Forschungszentrum Fuer Molekulare Medizin Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cemm Forschungszentrum Fuer Molekulare Medizin Gmbh filed Critical Cemm Forschungszentrum Fuer Molekulare Medizin Gmbh
Publication of SG11202002570WA publication Critical patent/SG11202002570WA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0669—Bone marrow stromal cells; Whole bone marrow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202002570WA 2017-10-31 2018-10-30 Methods for determining selectivity of test compounds SG11202002570WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17199353 2017-10-31
PCT/EP2018/079746 WO2019086476A1 (en) 2017-10-31 2018-10-30 Methods for determining selectivity of test compounds

Publications (1)

Publication Number Publication Date
SG11202002570WA true SG11202002570WA (en) 2020-04-29

Family

ID=60413039

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202002570WA SG11202002570WA (en) 2017-10-31 2018-10-30 Methods for determining selectivity of test compounds

Country Status (10)

Country Link
US (1) US20210181183A1 (zh)
EP (1) EP3704484A1 (zh)
JP (1) JP7478094B2 (zh)
KR (1) KR20200079296A (zh)
CN (1) CN111295588A (zh)
AU (1) AU2018359500A1 (zh)
CA (1) CA3079134A1 (zh)
IL (1) IL274074A (zh)
SG (1) SG11202002570WA (zh)
WO (1) WO2019086476A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201806188D0 (en) * 2018-04-16 2018-05-30 Bailey David Stanley Methods for cell profiling
CA3119297A1 (en) * 2018-11-14 2020-05-22 Dana-Farber Cancer Institute, Inc. Determining treatment response in single cells
CN116083512A (zh) * 2021-12-28 2023-05-09 珠海市藤栢医药有限公司 受试物的生物活性的检测方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129019T1 (de) * 1990-05-07 1995-10-15 Dade Int Inc Verfahren und vorrichtung zur ausführung des zytotoxizitätsassays auf tumorzellen.
FR2754544B1 (fr) 1996-10-10 1998-11-06 Lorraine Laminage Tole aluminiee a faible emissivite
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US6576291B2 (en) 2000-12-08 2003-06-10 Massachusetts Institute Of Technology Preparation of nanocrystallites
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
US20030027229A1 (en) * 2001-06-01 2003-02-06 Cytovia, Inc. Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosis
CA2453450A1 (en) 2001-07-20 2003-11-06 Quantum Dot Corporation Luminescent nanoparticles and methods for their preparation
US7981667B2 (en) 2003-05-07 2011-07-19 Indiana University Research And Technology Corporation Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto
KR100657891B1 (ko) 2003-07-19 2006-12-14 삼성전자주식회사 반도체 나노결정 및 그 제조방법
WO2005061707A1 (ja) 2003-12-24 2005-07-07 Kyowa Hakko Kogyo Co., Ltd. 癌細胞のEg5阻害剤に対する感受性を判定する方法
WO2006033972A2 (en) * 2004-09-15 2006-03-30 Protometrix, Inc. Protein arrays and methods of use thereof
AU2010206843B2 (en) * 2009-01-20 2015-01-29 The Board Of Trustees Of The Leland Stanford Junior University Single cell gene expression for diagnosis, prognosis and identification of drug targets
BRPI1012980A2 (pt) 2009-05-19 2016-03-29 Vivia Biotech Sl dispositivo e métodos para analisar a capacidade de resposta celular e a resposta de células neoplásticas a drogas
US20110129822A1 (en) 2009-12-01 2011-06-02 Precision Therapeutics, Inc. Multi drug response markers for breast cancer cells
WO2011149013A1 (ja) 2010-05-26 2011-12-01 株式会社Ｒｅｉメディカル 癌組織由来細胞塊または癌細胞凝集塊の薬剤または放射線感受性評価方法
US20140093953A1 (en) * 2012-10-01 2014-04-03 The Regents Of The University Of Michigan Non-adherent cell support and manufacturing method
EP3198276B1 (en) 2014-09-24 2023-09-20 Exscientia GmbH Monolayer of pbmcs or bone-marrow cells and uses thereof
WO2017143287A1 (en) * 2016-02-18 2017-08-24 University Of South Florida Methods of screening drugs for cancer treatment using cells grown on a fiber-inspired smart scaffold

Also Published As

Publication number Publication date
JP2021500912A (ja) 2021-01-14
KR20200079296A (ko) 2020-07-02
IL274074A (en) 2020-06-30
EP3704484A1 (en) 2020-09-09
WO2019086476A1 (en) 2019-05-09
US20210181183A1 (en) 2021-06-17
JP7478094B2 (ja) 2024-05-02
CA3079134A1 (en) 2019-05-09
AU2018359500A1 (en) 2020-03-19
CN111295588A (zh) 2020-06-16

Similar Documents

Publication Publication Date Title
IL286853B (en) Methods for diagnosing sepsis
ZA201900945B (en) Methods for detecting aav
SG11201703756RA (en) Determining timing for determination of applicable geo-fences
DK3384274T3 (da) Fremgangsmåder til prøvekarakterisering
ZA202002137B (en) Methods of detecting transthyretin
ZA201803445B (en) Apparatus for determining the weight of an object
HK1246184A1 (zh) 作為a7-烟碱乙酰膽碱受體激動劑的氨基苯並惡唑化合物
IL274074A (en) Methods for determining selectivity of test compounds
EP3308149C0 (en) SENSOR FOR NON-DESTRUCTIVE CHARACTERIZATION OF OBJECTS
GB2560668B (en) Biomolecule measurement apparatus
IL269561A (en) measurement method
IL289609A (en) High accuracy of relative defect locations for repeater testing
KR101831531B9 (ko) 생체 시료의 선별적 분석방법
GB2539420B (en) Determination of chromatography conditions
EP3128326A4 (en) Biomarker for diagnosis of aging or amyotrophia
EP3385698C0 (de) Verfahren zur analyse von oberflächenmessungen
ZA201708254B (en) Biomarkers for detection of tuberculosis risk
EP3380515A4 (en) Kits for detection of hepcidin
IL247160A0 (en) A method for determining an array of an object
GB201605170D0 (en) Method of detecting use of tuning kit
GB201515070D0 (en) Method for determining affinity of a biomolecule
IL269712B (en) Techniques for making time-of-flight measurements
EP3635377C0 (fr) Procédé de détermination de propriétés physiques d'un échantillon
GB201615818D0 (en) Methods of systems for analysis
PL3305432T3 (pl) Środek kontrolny do zamykarki puszek